Drug Guide
 

Gemtuzumab-Ozogamicin

Bookmark
  •  
    IV
    Gemtuzumab-Ozogamicin
    Mylotarg 
    • Mechanism of Action
    • Contains a monoclonal antibody directed toward CD-33 linked to a chemotherapeutic agent, allowing for targeted delivery of cytotoxic chemotherapy to CD33-positive cells.
      The chemotherapeutic agent, N-acetyl gamma calicheamicin, is activated within targeted cells and induces double-standed DNA breaks.

Clinical Use

    • Indication
    • CD33 positive acute myeloid leukaemia.
    • Adverse Effects
    • Infusion reactions
    • Hepatotoxicity
    • Haemorrhage
    • Infections
Want more info like this?
  • Your electronic clinical medicine handbook
  • Guides to help pass your exams
  • Tools every medical student needs
  • Quick diagrams to have the answers, fast
  • Quizzes to test your knowledge
Explore
   
 
Feedback